Right to Health

SouthViews No. 135, 17 November 2016

Actions Needed Urgently to Tackle Air Pollution – Part 2

By Martin Khor

Actions are urgently needed to curb air pollution, which has emerged as the biggest threat to health and the environment, and they need to be taken at global and national levels. (This is the second of two articles on air pollution.) This article was published by Inter Press Service (IPS) on 14 November 2016. (more…)

SouthViews No. 134, 16 November 2016

Air Pollution Emerges as a Top Killer Globally – Part 1

By Martin Khor

New research is showing that air pollution is a powerful if silent killer, causing 6.5 million worldwide deaths as well as being the major cause of climate change. Air pollution has emerged as a leading cause of deaths and serious ailments in the world. Emissions that cause air pollution and are Greenhouse Gases are also the main factor causing climate change. Therefore, drastically reducing air pollution should now be treated as a top priority. (more…)

SouthViews No. 129, 11 August 2016

Uruguay’s victory over Philip Morris: a win for tobacco control and public health

By Germán Velásquez

In a landmark decision that has been hailed as a victory of public health measures against narrow commercial interests, an international tribunal has dismissed a claim by tobacco giant company Philip Morris that the Uruguay government violated its rights by instituting tobacco control measures. The ruling had been much anticipated as it was the first international case brought against a government for taking measures to curb the marketing of tobacco products. (more…)

SouthViews No. 121, 12 November 2015

The grant of patents and the exorbitant cost of “lifesaving” drugs

By Germán Velásquez

The important relationship between the examination of patents carried out by national patent offices and the right of citizens to access to medicines hasn’t always been well understood. Too often these are viewed as unrelated functions or responsibilities of the state. And the reason is clear: patentability requirements are not defined by patent offices, but frequently by the courts, tribunals, legislation or treaty negotiators. This is the case when patent policy is implemented in isolation from, rather than guided by, public health policy. (more…)

SouthViews No. 103, 8 April 2014

A matter of life and death

By Martin Khor

Of all the issues currently being negotiated on the Trans Pacific Partnership Agreement, none are more important than the ability of patients to get life-saving medicines at affordable prices, which many fear may be a victim of the agreement. (more…)